Identification of a new Pyk2 target protein with Arf-GAP activity

被引:0
|
作者
Andreev, J
Simon, JP
Sabatini, DD
Kam, J
Plowman, G
Randazzo, PA
Schlessinger, J
机构
[1] NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA
[2] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA
[3] NYU, Med Ctr, Skirball Inst, New York, NY 10016 USA
[4] NCI, Div Basic Sci, Cellular Oncol Lab, Bethesda, MD 20892 USA
[5] Sugen Inc, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein tyrosine kinase Pyk2 is activated by a variety of G-protein-coupled receptors and by extracellular signals that elevate intracellular Ca2+ concentration. We have identified a new Pyk2 binding protein designated Pap. Pap is a multidomain protein composed of an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal SH3 domain. We demonstrate that Pap forms a stable complex with Pyk2 and that activation of Pyk2 leads to tyrosine phosphorylation of Pap in living cells. Immunofluorescence experiments demonstrate that Pap is localized in the Golgi apparatus and at the plasma membrane, where it is colocalized with Pyk2. In addition, in vitro recombinant Pap exhibits strong GTPase-activating protein (GAP) activity towards the small GTPases Arf1 and Arf5 and weak activity towards Arf6. Addition of recombinant Pap protein to Golgi preparations prevented Arf-dependent generation of post-Golgi vesicles in vitro. Moreover, overexpression of Pap in cultured cells reduced the constitutive secretion of a marker protein. We propose that Pap functions as a GAP for Arf and that Pyk2 may be involved in regulation of vesicular transport through its interaction with Pap.
引用
收藏
页码:2338 / 2350
页数:13
相关论文
共 50 条
  • [1] Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-associated protein β
    Mandiyan, V
    Andreev, J
    Schlessinger, J
    Hubbard, SR
    EMBO JOURNAL, 1999, 18 (24): : 6890 - 6898
  • [2] Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis
    Zhang, Yingzhen
    Yang, Xiaoli
    Li, Zhongzhong
    Bu, Kailin
    Li, Tong
    Ma, Zhizhao
    Wang, Binbin
    Ma, Lina
    Lu, Honglin
    Zhang, Kun
    Liu, Luji
    Zhao, Yanying
    Zhu, Yipu
    Qin, Jin
    Cui, Junzhao
    Liu, Lin
    Liu, Shuxia
    Fan, Ping
    Liu, Xiaoyun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [3] PYK2 as a therapeutic target for pancreatic cancer
    Hu, Jing
    Gao, Chenxi
    Chen, Guangming
    Gao, Xuan
    Zhang, Dennis H.
    Kuan, Shih-Fan
    CANCER RESEARCH, 2017, 77
  • [4] STAP-2 interacts with Pyk2 and enhances Pyk2 activity in T-cells
    Saitoh, Kodai
    Tsuchiya, Takuya
    Kashiwakura, Jun-ichi
    Muromoto, Ryuta
    Kitai, Yuichi
    Sekine, Yuichi
    Oritani, Kenji
    Matsuda, Tadashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 488 (01) : 81 - 87
  • [5] The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1
    Kruljac-Letunic, A
    Moelleken, J
    Kallin, A
    Wieland, F
    Blaukat, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) : 29560 - 29570
  • [6] Regulation of membrane trafficking and organ separation by the NEVERSHED ARF-GAP protein
    Liljegren, Sarah J.
    Leslie, Michelle E.
    Darnielle, Lalitree
    Lewis, Michael W.
    Taylor, Sarah M.
    Luo, Ruibai
    Geldner, Niko
    Chory, Joanne
    Randazzo, Paul A.
    Yanofsky, Martin F.
    Ecker, Joseph R.
    DEVELOPMENT, 2009, 136 (11): : 1909 - 1918
  • [7] PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target
    Sbrana, Francesca Vittoria
    Fiordi, Benedetta
    Bordini, Jessica
    Belloni, Daniela
    Barbaglio, Federica
    Russo, Luca
    Scarfo, Lydia
    Ghia, Paolo
    Scielzo, Cristina
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (04) : 576 - 586
  • [8] PYK2 as a Novel Therapeutic Target for Pancreatic Cancer
    Hu, J.
    PANCREAS, 2017, 46 (10) : 1407 - 1407
  • [9] Somatic mutations in Pyk2 in melanoma alter protein activity, interactions and localization
    Willard, Melinda D.
    Wulur, Isabella H.
    Samuels, Yardena
    Barber, Thomas D.
    Gartner, Jared
    Parker, Stephen C. J.
    CANCER RESEARCH, 2012, 72
  • [10] Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling
    Dikic, I
    Dikic, I
    Schlessinger, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14301 - 14308